BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 15, 2012
View Archived Issues
Astellas Pharma highlights progress of third quarter of fiscal 2011
Read More
Maruho acquires U.S. company
Read More
Amarin gives update on FDA's review of AMR-101 NDA
Read More
Synthetic mast cell microparticles serve as vaccine adjuvants
Read More
Superhydrophobic materials allowing slow drug release designed in U.S.
Read More
New phase III data support once-weekly exenatide use for diabetes type 2
Read More
New prostanoid DP2 receptor antagonists prepared at Ironwood Pharmaceuticals
Read More
New metabotropic glutamate mGlu4 receptor modulators identified
Read More
Bayer Schering Pharma divulges novel protein kinase inhibitors
Read More
Nippon Chemiphar patents new candidate therapies for urinary incontinence
Read More
Novartis announces new prostanoid IP1 receptor agonists
Read More
Addex Pharmaceuticals designs new modulators of metabotropic glutamate mGlu4 receptor
Read More
RedHill Biopharma clear to conduct advanced-stage RHB-102 trial
Read More
Tiltan Pharma begins phase II study of TL-118
Read More
Soligenix announces promising results on SGX-201
Read More
Burnet Institute to receive grant for tuberculosis biomarkers
Read More
Compendia Bioscience enters partnership for next-generation cancer therapeutics
Read More
PROLOR Biotech reports additional preclinical data on long-acting clotting factor
Read More
Biogen Idec to acquire biotechnology company
Read More
Ziopharm reports encouraging overall survival data from study in soft tissue sarcoma
Read More
Columbia Laboratories transfers progesterone vaginal gel NDA
Read More
Phosphagenics reports results from trial of improved oxycodone patch
Read More
Phase II letermovir trial meets primary efficacy endpoints
Read More
Study provides proof of concept for TransVax cytomegalovirus vaccine
Read More
Newron and Meiji Seika Pharma finalize licensing agreement
Read More
SuppreMol reports interim phase Ib/IIa SM-101 data
Read More